Abstract
Mucormycosis is an angioinvasive infection caused by Zygomycosis in the order of Mucorales. It is mainly affected in immunocompromised individuals followed by risk factors such as diabetes mellitus, stem cell transplantation, organ transplantation, hematological malignancy, and more intake of steroids. Rhino-orbito-cerebral mucormycosis, pulmonary mucormycosis, cutaneous mucormycosis, gastrointestinal mucormycosis, and disseminated mucormycosis are the most common types. Moreover, it can be diagnosed to overcome this infection using the following methods such as histopathology cultures, computed axial tomography, and resonance imaging. Moreover, it can be treated with amphotericin B, the first-line drug, and posaconazole and isavuconazole are also used. The in vitro studies reveal the antifungal drugs which show the best activity against mucormycosis. The main aim of this review shows the detailed study of mucormycosis and the outcome of this infection.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
